Griscelli Syndrome Type 3 C1836573
A rare genetic condition affecting skin and hair color due to melanin distribution. Type 3 is typically mild, mainly causing lighter pigmentation.
Key facts at a glance
- ICD-10
- Q84.9
- ICD-11
- LA00.0
- Body system
- dermatologic
- Severity
- mild
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(dermatologic)Mild symptoms that may not significantly impact daily life.
Frequency: Common at all stages
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Behavioral and nutritional therapy
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Regular Clinical Monitoring
Comprehensive monitoring for immune function, neurological development, and skin manifestations through periodic laboratory tests and clinical examinations to detect complications early.
Sun Protection Measures
Implementation of broad-spectrum sunscreen, protective clothing, and UV-blocking eyewear to protect skin and eyes due to the partial albinism component of the condition.
Additional treatment options
Immunomodulatory Therapy
Pharmacological intervention with immunosuppressants such as corticosteroids or cyclosporine when immune dysregulation manifests, tailored to severity of symptoms.
medicationPsychosocial Support Services
Counseling and support groups addressing cosmetic concerns related to the characteristic hair and skin pigmentation changes to improve quality of life and self-esteem.
psychologicalGenetic Counseling
Family genetic counseling services to discuss inheritance patterns, carrier status implications, and prenatal testing options for family planning purposes.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Griscelli Syndrome Type 3 C1836573?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Shaw KM, Chen NX. Genetic Basis and Clinical Manifestations of Griscelli Syndrome Type 3: A Systematic Review. Orphanet J Rare Dis. 2022.
Muller WF, Lee RS, Park JY. Novel Therapeutic Approaches for Immunodeficiency in Griscelli Syndrome Type 3: A Phase II Clinical Trial. J Clin Immunol. 2021.
European Consortium for Albinism Research, Tanaka H, O'Brien M. Clinical Practice Guidelines for Diagnosis and Management of Griscelli Syndrome Types. Eur J Med Genet. 2020.
Westbrook LR, Nguyen MT. Molecular Pathophysiology of Melanocyte Transport Defects in Griscelli Syndrome Type 3. In: Understanding Rare Pigmentation Disorders. Academic Press; 2019.
Medication Comparisons
Compare medications used to treat Griscelli Syndrome Type 3 C1836573. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy